October 27, 2015
NORDIC NANOVECTOR: POSTER PRESENTATION OF PRECLINICAL STUDIES COMPARING BETALUTIN® WITH Lu-177 CHIMERIC ANTI-CD37 ANTIBODY RADIONUCLIDE CONJUGATE
Media
October 21, 2015
NORDIC NANOVECTOR: RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2015
October 20, 2015
WILSON THERAPEUTICS APPOINTS ANDREW KAY AS CHAIRMAN
October 16, 2015
Strongbridge Biopharma plc Announces Pricing of Its Initial U.S. Public Offering
October 15, 2015
Nordic Nanovector adapts clinical development plan for Betalutin® in Follicular Lymphoma
October 08, 2015
Nexstim Plc Supports 7th International Symposium on Navigated Brain Stimulation in Neurosurgery
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
September 26, 2015
Data Safety Monitoring Board Recommends Continuation of Nexstim Plc’s Phase III Stroke Therapy Trial
September 24, 2015
CERAMENT™ Antibiotic Eluting Bone Substitutes For The Management Of Osteomyelitis Prominent At The 34th Annual Meeting Of The European Bone & Joint Infection Society (EBJIS)
